Tag: Chemotherapy
Childhood Hodgkin Lymphoma Survivors at Risk for Later Cancers
Survivors have 14-fold increased risk for developing a solid subsequent malignant neoplasm
Myelodysplastic Syndrome/AML Risk Increased After Chemo
Since 2000, risks for therapy-related myelodysplastic syndrome, AML up after chemo for solid cancers
Modified-FOLFIRINOX Beneficial in Resected Pancreatic Cancer
Disease-free, overall survival significantly longer compared with gemcitabine, but more adverse events
Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer
Toxicity similar in two treatment groups at 24 months, but worse tumor control with cetuximab
Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy
Major bleeding occurred in more apixaban-treated than control patients
SABCS: T-DM1 Cuts Recurrent Invasive HER2+ Breast CA Risk
Risk reduced with trastuzumab emtansine in those with residual invasive dz at sx after neoadjuvant chemo
ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
Median progression-free survival improved with A+CHP vs CHOP; similar incidence of adverse events
SABCS: Delaying Chemo Lowers Survival in Triple-Neg Breast CA
Findings show delaying chemo over 30 days postsurgery lowers triple-negative breast cancer survival
FDA Approves New Treatment for Acute Myeloid Leukemia
Randomized clinical trial showed significant improvement in overall survival with Daurismo
Improved Long-Term Pregnancy Outcomes for Goserelin + Chemo
Findings seen in premenopausal women with stage I to IIIA hormone receptor-negative breast cancer
